Jason Shafrin, PhD

Healthcare Economist
Measuring the Value of Pharmaceuticals Over Time
02/27/2019
Jason Shafrin, PhD, explains the difficulty of measuring pharmaceutical value and notes ways in which ICER and IVI are attempting to address this challenge.
Jason Shafrin, PhD, explains the difficulty of measuring pharmaceutical value and notes ways in which ICER and IVI are attempting to address this challenge.
Jason Shafrin, PhD, explains the...
02/27/2019
Journal of Clinical Pathways
Healthcare Economist
Does a Drug’s Cost-Effectiveness Improve Over Time?
03/24/2020
Jason Shafrin, PhD, points to a recent study that shows clinical and cost effectiveness of a drug may improve over time; he asserts that this finding should be of importance to policymakers and payers.
Jason Shafrin, PhD, points to a recent study that shows clinical and cost effectiveness of a drug may improve over time; he asserts that this finding should be of importance to policymakers and payers.
Jason Shafrin, PhD, points to a...
03/24/2020
Journal of Clinical Pathways
Healthcare Economist
Understanding Price Growth in the Market for Targeted Oncology Therapies
06/20/2019
Jason Shafrin, PhD, asserts that patients and payers can justifiably complain about the rising prices of targeted therapies, but manufacturers can rightfully argue that the prices need to be this high to maintain revenues.
Jason Shafrin, PhD, asserts that patients and payers can justifiably complain about the rising prices of targeted therapies, but manufacturers can rightfully argue that the prices need to be this high to maintain revenues.
Jason Shafrin, PhD, asserts that...
06/20/2019
Journal of Clinical Pathways
Healthcare Economist
Impact of COVID-19 on CMS’ Value-Based Programs
06/01/2021
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses...
06/01/2021
Journal of Clinical Pathways
Hospitalization Risk among Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics: A Long-Term Retrospective Analysis of Medicaid Claims Data
Objective: To compare the risk of hospitalization for adults with bipolar I disorder (BPD-I) when treated with lurasidone vs. other atypical antipsychotics (AAPs) as monotherapy.
10/08/2020
Healthcare Economist
What Is a Patient-Informed Societal Perspective CEA Model?
06/28/2019
Jason Shafrin, PhD, sheds light on a study that argues that patients are underrepresented in traditional cost-effectiveness analysis and that a patient-informed societal perspective is needed.
Jason Shafrin, PhD, sheds light on a study that argues that patients are underrepresented in traditional cost-effectiveness analysis and that a patient-informed societal perspective is needed.
Jason Shafrin, PhD, sheds light...
06/28/2019
Journal of Clinical Pathways
Healthcare Economist
The Real Cost of Electronic Health Records
06/07/2021
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses...
06/07/2021
Journal of Clinical Pathways
Implementation of Digital Health Technologies for Real-time Monitoring of Patients With Serious Mental Illness: What Lessons Can Be Learned and Applied From Other Specialties?
Introduction: Evaluation of patients with serious mental illness (SMI) relies largely on patient or caregiver self-reported disease symptoms. New technologies (e.g., mobile-based interven...
11/22/2019
Healthcare Economist
EHR and Physician Burnout
07/15/2019
Jason Shafrin, PhD, comments on how EHRs must improve to be able to balance physician quality of life with quality patient care.
Jason Shafrin, PhD, comments on how EHRs must improve to be able to balance physician quality of life with quality patient care.
Jason Shafrin, PhD, comments on...
07/15/2019
Journal of Clinical Pathways
Jason Shafrin, PhD, FTI Consulting
Guest Blog
Has Medicine Reached the Digital Age? Five Key Obstacles Digital Technologies Still Need to Overcome
08/26/2021
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David...
08/26/2021
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use